AIDS Treatment News - 2000

• AIDS Treatment News - 2000
• Issue #334
• 2000 Outlook
• Retroviruses Conference Report by Telephone Conference, February 2
• Lipodystrophy Report by Telephone Conference, Feb. 9
• Three Activist Meetings, San Francisco Late January
• Neuropathy: Practical Book on Mainstream, Alternative Options
• Acupuncture Detoxification Meeting, San Francisco, January 28 and 29
• Disability Benefits: New Law will Help Disabled Return to Work


• Issue #335
• Flu Epidemic: Shots, New Treatments Available
• Liver Toxicity, Ritonavir, and Hepatitis C: New Data Published
• Post-Exposure Prevention (PEP) for Sexual, Needle Exposure Opens in New York
• African Americans and AIDS Conference, February 24-25, Washington D.C.
• Retroviruses Conference, January 30 - February 2
• Reminder: Durban Conference Deadlines February 1


• Issue #336
• Retroviruses Conference: Overview, Information Available
• San Francisco: Retroviruses Conference Community Forum, Feb. 17
• Testosterone, Other Injectable Drug Access Problems in San Francisco Area: Call for Information
• Large Cuts in Public Hospital, Clinic HIV Services, San Francisco and NationalùWhy? B


• Issue #337
• A Call for More Cautious Antiretroviral Treatment
• St. John's Wort Warning: Do Not Combine with Protease Inhibitors, NNRTIs
• New Guidelines for HIV Treatment; Resistance Testing Now Recommended
• HIV Resistance-Testing Information on Web
• Abacavir Warning: Certain Respiratory Symptoms Can Indicate Hypersensitivity Reaction


• Issue #338
• HAART and Medical Management: The Realities of Clinic Care. Interview with Keith Henry, M.D.
• National AIDS Update Conference, San Francisco, March 14-17
• First Microbicide Conference, March 13-16 near Washington D.C.


• Issue #339
• Treatment Models from India: Interview with Shashank Joshi, M.D.
• Testosterone Cream Available at CPS; Gel Approved by FDA
• Anabolics, Exercise, Nutrition, Supplements: New Book Available
• Vaccine News, March 2, 2000
• Fluconazole: Pfizer Asked to Lower Africa Price
• Dietary Supplement Regulation: FDA Public Hearing April 4, Written Comments Due May 4
• FDA Drug-Approval Background: New Web Pages
• African Americans and AIDS: Highlights of 2nd Annual Washington Conference


• Issue #340
• AIDS Practice Issues Today: Interview with Paul Bellman, M.D.
• South Africa
• Pfizer Will Donate Fluconazole to South Africa
• New York: Immune-Based Therapies Teach-In, April 15


• Issue #341
• Treatment Interruption: Experts Sound Cautious Note at San Francisco Forum; Meeting Proceeds Despite Disruption
• Answering the AIDS Denialists: CD4 (T-Cell) Counts, and Viral Load
• ACT UP Golden Gate Changes Name to Survive AIDS
• Vaccines: Call Congress to Support R&D Tax Credit
• Africa Series Wins Pulitzer
• Treatment Fact Sheets: Call for Information
• Sign-On Statement Against U.S. Drug-Price Increases


• Issue #342
• AIDS Declared National Security Threat
• Conference Call on New Drugs and Strategies, May 23
• Amprenavir (AGENERASE«) Oral Solution: Warning for Some Patients
• Nevirapine (Viramune): European Warning
• Efavirenz (Sustiva(TM)): Oral Liquid Expanded Access Program for Children and Adolescents Ages 3-16
• Retroviruses Conference: New Printed Summary
• Prison and HIV or Hepatitis: June 17 Meeting in Washington
• AIDS Candlelight Memorial, May 21
• South Africa: Advisor Ian Roberts Resigns
• AIDS Denialists: How to Respond


• Issue #343
• Africa Treatment Access in the News
• Africa Access: Call for Information
• Resistance Testing Recommended in New IAS--USA Guidelines
• San Francisco: Misdemeanor Charges in Treatment Meeting Disruption
• Durban Conference Status, May 2000: Interview with Conference Chair Coovadia
• Endorsements Sought for Global March for HIV/AIDS Treatment, July 9, Durban
• Kiyoshi Kuromiya, 1943-2000


• Issue #344
• Treatment Interruption: Free Telephone Conference Call June 20
• New Oral DNA Vaccine Funded for Trials
• Frequent Urination, Leg Cramps, Leg Weakness, Erection Difficulties: HIV Myelopathy Amino Acid Study
• Clinical Trials and Industry Influence: Major Report
• "Mental" Issue Threatens Medical Care
• World Issues Today: Interview with Peter Piot, Executive Director of UNAIDS
• Global Health Council 2000 Conference, June 14-16 near Washington


• Issue #345
• Kaletra (tm) (ABT-378/r) Application for Accelerated Approval
• Durban World Conference, July 9-14: Online Coverage
• HIV/AIDS Clinical Update Published on Web
• HIV Drug Resistance Meeting: Reports on Web
• Bone, Hip Problems: Overview Article Online
• A No-Nonsense Guide to HIV Drug Resistance Testing
• Excellent Book on Gay Men's Health
• Urgent: South African Treatment Activists Need Assistance
• Durban: Global Call for Treatment Access
• Durban and South Africa Travel, Phone Tips
• FDA Public Meeting on Pharmacokinetics and Antiviral Response, July 25 near Washington D.C.


• Issue #346
• Durban Conference: Official Webcast
• Durban Conference: Teleconference Summary July 20
• Durban Declaration on HIV and AIDS
• San Francisco Statement on HIV and AIDS
• Communication Skills and HIV Prevention
• Tuberculosis: New Drug Class Investigated through Public-Private Partnership
• HMO, Insurance Policies Threaten HIV Care: Interview with Dr. X


• Issue #347
• Weekly Intermittent Treatment: Caution
• Selenium: Important New Review of Health Findings
• Access to Treatment Worldwide: From Talk to Action at Durban
• Selenium: African Studies Reported at Durban
• "HIV" Controversy: Nelson Mandela's Call to End Dispute


• Issue #348
• Philadelphia Protests: National Support Needed
• Marijuana Safety Study Completed: Weight Gain, No Safety Problems
• Other Medical Marijuana News
• Medicine Recycling to Latin America: Interview with Jes?s Ag?ais, AID for AIDS in New York
• Ziagen(r) (Abacavir): New Warning on Restarting


• Issue #349
• Side Effects, Lipodystrophy: Free Telephone Conference September 15
• Kaletra(tm) (ABT-378/r) Early Access Program Can Accept More Patients
• Scrub Typhus: Infection Reduces Viral Load in Some Patients
• ICAAC Research Conference: Free Telephone Summary September 19
• ICAAC, September 17 -20 in Toronto
• Global Resistance Day, September 16, Toronto
• Oakland, California: HIV Drug Resistance Talk, August 31
• Viral Hepatitis Summit for San Francisco Area Organizations
• United States Conference on AIDS, Atlanta, Georgia, October 1-4
• Health Insurance Reimbursement Legislation
• Prevention: Changing Focus in San Francisco
• ACT UP/Philadelphia Arrest Followup


• Issue #350
• AIDS Treatment Improves Survival: Answering the "AIDS Denialists"


• Issue #351
• Kaletra (ABT-378/r) Approve
• New Finding on Immune Response to HIV Tat May Contribute to Vaccine, Treatment
• Immune-Based Therapies: FDA Meeting October 16
• ICAAC, Lipodystrophy; IDSA: Conference Summaries on Web
• 2001 Retroviruses Conference, Chicago: Deadlines Start in October
• Brazil AIDS Success: Washington Post Report
• Critical Path Newsletter: Kiyoshi Kuromiya Memorial, Prison Resources
• Treatment and Survival Special Issue: How to Reprint for Clients


• Issue #352
• NAC: Stanford San Francisco Study Report Shows Blood Glutathione Improvement, Possible Survival Benefit
• NAC and Glutathione: Recent Publications


• Issue #353
• Vaccine Advance: Monkeys Still Infected, but Protected from Illness
• FDA Meeting on Approving Immune Therapies: Background and Comment
• South Africa: Historic "Defiance Campaign" Imports Generic Fluconazole
• Congress Considering Medicaid Coverage for Persons with HIV: Call Your Representatives
• HMOs, Health Insurance: More Problems


• Issue #354
• Enteric-Coated ddI Approved: FDA Letter
• Retroviruses Conference: Registration Deadline for Community Attendance is Nov. 17
• Durban Conference Searchable Abstracts Now Available on Web
• Bitter Publication Dispute on Remune Study: More Than Meets the Eye?
• Many People with HIV/AIDS Not Getting Proper Treatment
• Help Wanted: AIDS Writer for AmFAR in New York
• AIDS Treatment News Price Increase January 1; Act Now to Renew at Current Rate
• HIV Treatment and Survival: Easy Language Version
• Has Anti-HIV Treatment Cut AIDS Deaths? (original for copying)


• Issue #355
• Community Update: New Drugs to Watch
• Nevirapine (VIRAMUNE(r)) Strengthens Warning on Liver, Skin Toxicities
• "Trizivir" Approved: Three Existing Drugs in One
• Nutrition and HIV Infection: Experience in Zimbabwe Interview with Lynde Francis
• AIDS Treatment News Will Move to Philadelphia on January 2


• Issue #356
• Structured Treatment Interruption: Important Controlled Trial in Monkeys
• Superinfection (Reinfection): New Study in San Francisco Offers Free Resistance and Viral Load Testing
• New Report on World AIDS Epidemic
• Global Treatment Access: Call for 95% Price Reduction; New GTAC Organization, Web Site
• California: MediCal Income Eligibility Level Raised for Disabled, Aged
• Answering the AIDS Denialists: Is AIDS Real?


• Issue #357
• European Jewish Ancestry: Activist Doctor Needs Stem Cell Donation
• University of California AIDS Research: Conference February 16, Los Angeles
• Help Wanted: Executive Director, Washington D.
• Medicine Recycling: List of Donation Centers Published December 2000
• Buyers' Club List, December 2000
• AIDS Treatment News Index, 2000

All information on AIDS.ORG is designed to support, but not replace your relationship with your doctor, and is intended soley for educational or research purposes. Any and all personal information you may provide us with is never released to anyone at any time. Your privacy and trust is extremely important to us.

• News
• Topics
• Experience
• Donate
• About Us

• Headlines
• AIDS Treatment News